Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,393,580 papers from all fields of science
Search
Sign In
Create Free Account
noladin ether
Known as:
2-arachidonyl glyceryl ether
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Glycerides
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
Endocannabinoids modulate human blood–brain barrier permeability in vitro
William H. Hind
,
C. Tufarelli
,
Maria Neophytou
,
S. Anderson
,
T. England
,
S. O’Sullivan
British Journal of Pharmacology
2015
Corpus ID: 13984187
Endocannabinoids alter permeability at various epithelial barriers, and cannabinoid receptors and endocannabinoid levels are…
Expand
Review
2010
Review
2010
Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease.
S. O’Sullivan
,
Dave Kendall
Immunobiology
2010
Corpus ID: 22798488
Review
2008
Review
2008
The role of the CB1 receptor in the regulation of sleep
E. Murillo-Rodríguez
Progress in Neuro-psychopharmacology and…
2008
Corpus ID: 43081811
2006
2006
Noladin ether acts on trabecular meshwork cannabinoid (CB1) receptors to enhance aqueous humor outflow facility.
Y. Njie
,
Akhilesh Kumar
,
Zhuanhong Qiao
,
L. Zhong
,
Z. Song
Investigative Ophthalmology and Visual Science
2006
Corpus ID: 6640412
PURPOSE To study the effects of 2-arachidonyl glyceryl ether (noladin ether), an endocannabinoid ligand selective for cannabinoid…
Expand
Highly Cited
2005
Highly Cited
2005
Binding affinity and agonist activity of putative endogenous cannabinoids at the human neocortical CB1 receptor.
M. Steffens
,
J. Zentner
,
J. Honegger
,
T. Feuerstein
Biochemical Pharmacology
2005
Corpus ID: 20573375
Highly Cited
2005
Highly Cited
2005
The Endocannabinoid Noladin Ether Acts as a Full Agonist at Human CB2 Cannabinoid Receptors
J. L. Shoemaker
,
Biny K. Joseph
,
Michael B. Ruckle
,
P. Mayeux
,
P. Prather
Journal of Pharmacology and Experimental…
2005
Corpus ID: 10316149
Noladin ether (NE) is a putative endogenously occurring cannabinoid demonstrating agonist activity at CB1 receptors. Because of…
Expand
2005
2005
Differential effects of endocannabinoids on [3H]-GABA uptake in the rat globus pallidus
K. Venderová
,
T. Brown
,
J. Brotchie
Experimental Neurology
2005
Corpus ID: 34987539
2005
2005
Fatty acid amidohydrolase in human neocortex—activity in epileptic and non-epileptic brain tissue and inhibition by putative endocannabinoids
M. Steffens
,
A. Schulze-Bonhage
,
R. Surges
,
T. Feuerstein
Neuroscience Letters
2005
Corpus ID: 25367689
Review
2002
Review
2002
Endocannabinoids and related fatty acid derivatives in pain modulation.
J. Walker
,
Jocelyn F Krey
,
Constance J. Chu
,
Susan M. Huang
Chemistry and Physics of Lipids
2002
Corpus ID: 8908696
Highly Cited
2002
Highly Cited
2002
Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid.
Krista Laine
,
K. Järvinen
,
R. Mechoulam
,
A. Breuer
,
T. Järvinen
Investigative Ophthalmology and Visual Science
2002
Corpus ID: 17682823
PURPOSE The endogenous cannabinoids N-arachidonylethanolamide (AEA) and 2-arachidonylglycerol (2-AG) are known to decrease…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE